Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Furthermore, its potential effects on appetite regulation and sexual function have led to investigations into broader therapeutic uses
This biological change removes the psychological burden of constant hunger that makes traditional dieting unsustainable
Description Retatrutide 10 mg is a triple-agonist research peptide developed by Eli Lilly that simultaneously activates the GLP-1, GIP, and glucagon receptors
Retatrutide is not FDA-approved and should only be used in research settings following trial protocols
US$ 29.02
US$ 28.70
US$ 23.58
US$ 27.13
